Table 1.

Methotrexate, sulfasalazine, and hydroxychloroquine use by sex within each country*.

CountrySample SizeMethotrexateSulfasalazineHydroxychloroquine
MenWomenMenWomenMenWomenMenWomen
South Africa74 (16.9)364 (83.1)72 (97.3)329 (90.7)1 (1.4)8 (2.2)9 (12.2)52 (14.3)
USA44 (27.5)116 (72.5)32 (72.7)75 (64.7)1 (2.3)4 (3.4)5 (11.4)40 (34.5)
Portugal96 (27.4)254 (72.6)73 (76.0)174 (68.5)6 (6.3)14 (5.5)10 (10.4)29 (11.4)
Netherlands173 (31.9)370 (68.1)70 (40.5)157 (42.4)24 (13.9)60 (16.2)24 (13.9)95 (25.7)
Mexico11 (8.5)119 (91.5)10 (90.9)68 (57.1)0 (0)18 (15.1)0 (0)6 (5.0)
India493 (16.0)2580 (84.0)342 (69.4)1722 (67.0)146 (29.6)506 (19.6)191 (38.7)1332 (51.6)
Ireland61 (28.4)154 (81.6)24 (39.3)78 (50.6)34 (55.7)51 (33.1)0 (0)15 (9.7)
UK153 (35.9)273 (63.1)125 (81.7)227 (83.2)74 (48.4)122 (44.7)82 (53.6)160 (58.6)
  • * Data from Supplementary Tables 2–93. Values are n (%).